A Game-Changing Pill For Postpartum Depression Was Just Approved By The FDA
Feinstein Institute A photo of zuranolone, the first pill designed to treat postpartum depression, from its phase 3 clinical trial. The Food and Drug Administration on Friday approved the first-ever pill specifically designed to treat postpartum depression. Taken once a day for two weeks, the drug, called zuranolone and marketed as Zurzuvae, can rapidly and […]